Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sai-Qun Lv"'
Autor:
Yao Huang, Sai‐qun Lv, Pin‐yi Liu, Zhen‐long Ye, Huan Yang, Lin‐fang Li, Hai‐li Zhu, Ying Wang, Lian‐zhen Cui, Du‐qing Jiang, Fang‐yuan Hao, Hui‐min Xu, Hua‐jun Jin, Qi‐jun Qian
Publikováno v:
Molecular Oncology, Vol 14, Iss 3, Pp 657-668 (2020)
Oncolytic viruses armed with therapeutic transgenes of interest show great potential in cancer immunotherapy. Here, a novel oncolytic adenovirus carrying a signal regulatory protein‐α (SIRPα)‐IgG1 Fc fusion gene (termed SG635‐SF) was construc
Externí odkaz:
https://doaj.org/article/6e09193f43ee4072aad0ed3ba30d4874
Autor:
Jie-Ying Xu, Zhen-Long Ye, Du-Qing Jiang, Jiang-Chuan He, Yong-Mei Ding, Lin-Fang Li, Sai-Qun Lv, Ying Wang, Hua-Jun Jin, Qi-Jun Qian
Publikováno v:
Tumor Biology, Vol 39 (2017)
Chimeric antigen receptor modified T cell–based immunotherapy is revolutionizing the field of cancer treatment. However, its potential in treating bile duct carcinoma has not been fully explored. Herein, we developed the second-generation mesotheli
Externí odkaz:
https://doaj.org/article/32e48730b9f84f689a7692236120359a
Autor:
Lian zhen Cui, Huan Yang, Yao Huang, Hui min Xu, Sai qun Lv, Zhen long Ye, Du qing Jiang, Hua jun Jin, Hai li Zhu, Lin fang Li, Ying Wang, Fang yuan Hao, Qi jun Qian, Pin yi Liu
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 14, Iss 3, Pp 657-668 (2020)
Molecular Oncology, Vol 14, Iss 3, Pp 657-668 (2020)
Oncolytic viruses armed with therapeutic transgenes of interest show great potential in cancer immunotherapy. Here, a novel oncolytic adenovirus carrying a signal regulatory protein‐α (SIRPα)‐IgG1 Fc fusion gene (termed SG635‐SF) was construc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fcd017921526fe802640983c50e0600
http://europepmc.org/articles/PMC7053234
http://europepmc.org/articles/PMC7053234
Autor:
Zhang Zhiwei, He Jiangchuan, Qijun Qian, Wenxia Qin, Sai-Qun Lv, Huajun Jin, Linfang Li, Jiang Duqing, Qi Zhang, Liu Xiangzhen, Cui Lianzhen
Publikováno v:
Cellular Immunology. 329:31-40
Patients with pancreatic cancer have a poor prognosis largely due to the poor efficacy of the available treatment modalities. In this study, we engineered mesothelin-targeting chimeric antigen receptor T cells (mesoCAR T) using the piggyBac transposo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34c43e077c22a64a92d5b5ccc1911060
https://doi.org/10.1016/j.cellimm.2018.04.007
https://doi.org/10.1016/j.cellimm.2018.04.007
Autor:
Jing-lei Zhang, Tao Liu, Sai-Qun Lv, Linfang Li, Zenghui Xu, Huajun Jin, Ye Zhenlong, Qijun Qian, Luo-ning Zheng, Yao Huang, Hui Liu, Gao Haixia, Hai-Li Zhu
Publikováno v:
Acta Pharmacologica Sinica. 36:1237-1245
Argonaute2 (AGO2) protein is the active part of RNA-induced silencing complex, cleaving the target mRNA strand complementary to their bound siRNA. An increasing number of miRNAs has been identified as essential to angiogenesis of hepatocellular carci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7cb0d551b850054a3cb130acae16188
https://doi.org/10.1038/aps.2015.18
https://doi.org/10.1038/aps.2015.18
Autor:
Sai-Qun Lv, Huajun Jin, Ye Zhenlong, Hui Liu, Liu Pinyi, Yao Huang, Qijun Qian, Linfang Li, Hai-Li Zhu
Publikováno v:
Journal of Cancer
Targeting cancer stem cells with oncolytic virus (OV) holds great potential for thorough elimination of cancer cells. Based on our previous studies, we here established 11R-P53 and mGM-CSF carrying oncolytic adenovirus (OAV) SG655-mGMP and investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4f56824d95ef4f2c2319e0a8c9be67
https://pubmed.ncbi.nlm.nih.gov/28243324
https://pubmed.ncbi.nlm.nih.gov/28243324
Autor:
Xu Jieying, He Jiangchuan, Sai-Qun Lv, Jiang Duqing, Ye Zhenlong, Qijun Qian, Ying Wang, Linfang Li, Huajun Jin, Yong-Mei Ding
Publikováno v:
Tumor Biology, Vol 39 (2017)
Chimeric antigen receptor modified T cell–based immunotherapy is revolutionizing the field of cancer treatment. However, its potential in treating bile duct carcinoma has not been fully explored. Herein, we developed the second-generation mesotheli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc68e4a6230ef916f01f56ae068d1dd6
https://doi.org/10.1177/1010428317695949
https://doi.org/10.1177/1010428317695949
Autor:
Jiahe Yang, Huanzhang Hu, Changqing Su, Linfang Li, Qijun Qian, Meng-Chao Wu, Sai-Qun Lv, Xinyuan Liu, Xiaoning Wang, Jiang Li, Jin Huajun, Yao Huang, Chengliang Zhou
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e21307 (2011)
PLoS ONE
PLoS ONE
Highly selective therapy for hepatocellular carcinoma (HCC) remains an unmet medical need. In present study, we found that the tumor suppressor microRNA, let-7 was significantly downregulated in a proportion of primary HCC tissues (12 of 33, 36.4%) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62bb903fb158ae4421952f1621806f0f
http://europepmc.org/articles/PMC3140979?pdf=render
http://europepmc.org/articles/PMC3140979?pdf=render
Autor:
Jie-Ying Xu, Zhen-Long Ye, Du-Qing Jiang, Jiang-Chuan He, Yong-Mei Ding, Lin-Fang Li, Sai-Qun Lv, Ying Wang, Hua-Jun Jin, Qi-Jun Qian
Publikováno v:
Tumor Biology (IOS Press); Apr2017, Vol. 39 Issue 4, p1-11, 11p, 1 Chart, 5 Graphs